Trexquant Investment’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-14,277
Closed -$409K 1476
2018
Q4
$409K Sell
14,277
-8,841
-38% -$251K 0.03% 675
2018
Q3
$645K Buy
+23,118
New +$650K 0.05% 471
2017
Q3
Sell
-17,387
Closed -$436K 1160
2017
Q2
$436K Buy
17,387
+8,926
+105% +$221K 0.12% 301
2017
Q1
$227K Buy
+8,461
New +$234K 0.03% 904
2016
Q4
Sell
-17,455
Closed -$436K 1231
2016
Q3
$436K Buy
+17,455
New +$407K 0.1% 351
2016
Q2
Sell
-25,500
Closed -$382K 1234
2016
Q1
$382K Sell
25,500
-32,200
-56% -$540K 0.04% 659
2015
Q4
$1.26M Buy
57,700
+33,900
+142% +$632K 0.11% 310
2015
Q3
$375K Sell
23,800
-15,100
-39% -$242K 0.03% 818
2015
Q2
$555K Buy
+38,900
New +$659K 0.06% 567

Other funds holding NXTM

Trexquant Investment's NXTM Position: Q1 2019 in Review

Trexquant Investment sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 14,277 shares — an estimated $409K sold.

Trexquant Investment first reported a position in NXTM in Q2 2015 and held it in 9 quarters. The position peaked at $1.26M in Q4 2015. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Trexquant Investment reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Trexquant Investment sold 14,277 NxStage Medical Inc. shares in Q1 2019, an estimated $409K.
  • Trexquant Investment first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 9 quarters.
  • Trexquant Investment's NxStage Medical Inc. position peaked at $1.26M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.